Citations

Mayo Clinic

Showing 10 of 108523 citations.

Recruitment strategies and consent rates in a national prospective colorectal cancer screening cohort: results from year 1 of the Voyage Study
Yost, Kathleen J. , Carlson, Rachel E. , Kirt, Christine R., Kirsch, Emily J., Kneedler, Bonny , Laffin, Jennifer , Grimm, Jessica A. , Olson, Janet E., Grimm, Jessica A , Sauver, Jennifer L. St. , Rutten, Lila J. Finney , Olson, Janet E.

BMJ Open Gastroenterology | July 17, 2024 | Volume: 11 | Issue: 1 | Pages: e001376

10.1136/bmjgast-2024-001376 | PMID 39019622 Get It

Objective To identify the optimal incentive protocol for maximising participation while managing study costs during the Voyage trial. Design Prospective cohort (Voyage trial) of colorectal cancer (CRC) incidence and mortality outcomes in individuals screened with multitarget stool DNA (mt-sDNA) served as the population. A subset was randomised to receive postage stamps as a pre-consent incentive, or as a post-consent incentive after completion of the consent and questionnaire. Descriptive statistics from year 1 are reported. Results During year 1 of the Voyage trial, a total of 600 258 individuals with mt-sDNA orders received at Exact Sciences Laboratories were randomly selected and invited to participate. Of those, 26 429 (4.4%) opted in, 14 365 of whom (54.3%) consented. The opt-in and consent samples were similar to the target population with respect to sex but differed by geographic residence and age (p<0.001). For the embedded incentive experiment, 2333 were randomised to the pre-incentive arm, while 2342 were randomised to the post-incentive arm. Overall consent rate in the incentive trial was 56.4% (60.9% for the pre-consent incentive arm (1421/2333) vs 52.0% for the post-consent incentive arm (1217/2342), p<0.001). Cost reduction was observed for the pre-consent incentive group, and higher response rates were seen among older versus younger individuals. Conclusions Pre-consent incentive option was associated with a higher participation rate and lower costs and was used for the remainder of study recruitment. CRC incidence and mortality vary with age; thus, adjusting for differential participation by age and region will be important in analyses of Voyage data. Trial registration number NCT04124406.
Comparative single-cell analysis reveals IFN-γ as a driver of respiratory sequelae after acute COVID-19
Li, Chaofan , Qian, Wei , Wei, Xiaoqin , Narasimhan, Harish , Wu, Yue , Arish, Mohd , Cheon, In Su , Tang, Jinyi , Santos, Gislane de Almeida , Sharifi, Kamyar , Kern, Ryan , Vassallo, Robert , de Almeida Santos, Gislane , Sharifi, Kamyar , Kern, R , Vassallo, Robert , Sun, Jie , Tang, J , Li, Chaofan , Li, Ying , Sun, Jie

Science Translational Medicine | July 17, 2024 | Volume: 16 | Issue: 756 | Pages: No page available

10.1126/scitranslmed.adn0136 | PMID 39018367 Get It

Postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) represent an urgent public health challenge and are estimated to affect more than 60 million individuals globally. Although a growing body of evidence suggests that dysregulated immune reactions may be linked with PASC symptoms, most investigations have primarily centered around blood-based studies, with few focusing on samples derived from affected tissues. Furthermore, clinical studies alone often provide correlative insights rather than causal mechanisms. Thus, it is essential to compare clinical samples with relevant animal models and conduct functional experiments to understand the etiology of PASC. In this study, we comprehensively compared bronchoalveolar lavage fluid single-cell RNA sequencing data derived from clinical PASC samples and a mouse model of PASC. This revealed a pro-fibrotic monocyte-derived macrophage response in respiratory PASC, as well as abnormal interactions between pulmonary macrophages and respiratory resident T cells, in both humans and mice. Interferon-γ (IFN-γ) emerged as a key node mediating the immune anomalies in respiratory PASC. Neutralizing IFN-γ after the resolution of acute SARS-CoV-2 infection reduced lung inflammation and tissue fibrosis in mice. Together, our study underscores the importance of performing comparative analysis to understand the cause of PASC and suggests that the IFN-γ signaling axis might represent a therapeutic target.
Associations Between Running Mechanics, Functional Lower Extremity Strength, and Stress Urinary Incontinence in Parous Female Runners
Ron, Nicole J., Dolbinski, Sarah C., Hodonicky, Elizabeth G., Middlebrook, Darby O., Olmstead, Sally R., Olsen, Sandra L., Ron, Eyal D. , Middlebrook, Darby O., Olsen, Sandra L., Hollman, John H.

Journal of Women's & Pelvic Health Physical Therapy | July 17, 2024 | Volume: 48 | Issue: 3 | Pages: 147-153

10.1097/jwh.0000000000000302 | PMID 39148952 Get It

Background: Women with stress urinary incontinence (SUI) may have altered running mechanics and reduced hip muscle strength compared with women without SUI. Little research has examined running metrics and functional lower extremity strength of parous runners. Objective: To determine whether SUI severity correlates with running metrics and lower extremity muscle strength among parous women. Study Design: This was a cross-sectional observational study of 22 parous participants (mean age 39.8 years, with a mean of 3.4 pregnancies and 8.1-year interval since last delivery). Methods: Participants completed the International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form (ICIQ-UI), Urinary Distress Inventory-6 (UDI-6), Colorectal-Anal Distress (CRAD) Inventory-8, and Pelvic Organ Prolapse Distress Inventory-6 (POPDI-6), and Questionnaire for Urinary Incontinence Diagnosis (QUID) and provided demographic, relevant running, and obstetric/gynecologic history information. After a brief warm-up, participants completed 30-second single-leg sit-to-stand tests bilaterally and a standardized 10-minute treadmill run with pod cadence assessment. Pearson-product moment correlation coefficients were calculated (α = .05). Results: Prolonged ground contact times were associated with higher ICIQ-UI SF (r= 0.523, P= .015), POPDI-6 (r= 0.694, P< .001), and UDI-6 scores (r= 0.577, P= .006), while lower cadences were associated with higher POPDI-6 (r=−0.550, P= .010) and UDI-6 scores (r=−0.444, P= .044). Conclusions: Parous female runners with more severe SUI and prolapse symptoms demonstrate altered running mechanics characterized by prolonged ground contact times and slower cadences.
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints
Tapper, Elliot B. , Goldberg, David S. , Parikh, Neehar D. , Welch, Nicole , Hameed, Bilal , Khalili, Mandana , Stolz, Andrew , Verna, Elizabeth C. , Brown, Robert S., VanWagner, Lisa B. , Moylan, Cynthia A. , Diehl, Anna Mae , Jones, Patricia D. , Shah, Vijay H. , Bajaj, Jasmohan S. , Group, for the LCN Study, Goldberg, David , Welch, Nicole , Khalili, Mandana , Stolz, Andrew , Sanyal, A J , VanWagner, Lisa B , Ladner, Daniela P , Moylan, Cynthia A , Jones, Patricia D , Loomba, Rohit , Simonetto, Douglas A , Bajaj, Jasmohan S , Parikh, Neehar D , Terrault, Norah A. , Sharpton, Suzanne R. , Brown, Robert S., Sanyal, Arun J. , Ladner, Daniela P. , Loomba, Rohit , Dasarathy, Srinivasan , Simonetto, Douglas A. , Group, for the LCN Study

American Journal of Gastroenterology | July 17, 2024 | Volume: 120 | Issue: 3 | Pages: 570-575

10.14309/ajg.0000000000002953 | PMID 39018024 Get It

INTRODUCTION: One of the primary goals of the Liver Cirrhosis Network (LCN) is to develop a cohort study to better understand and predict the risk of hepatic decompensation and other clinical and patient-reported outcomes among patients with Child A cirrhosis. METHODS: The LCN consists of a Scientific Data Coordinating Center and 10 clinical centers whose investigators populate multiple committees. The LCN Definitions and Measurements Committee developed preliminary definitions of cirrhosis and its complications by literature review, expert opinion, and reviewing definition documents developed by other organizations. The Cohort Committee developed the study protocol with the input of the steering committee. RESULTS: The LCN developed a prospective cohort study to describe and predict the rates of incident clinical events pertaining to first decompensation and patient-reported outcomes. The LCN developed a pragmatic definition of compensated cirrhosis incorporating clinical, laboratory, imaging, and histological criteria. Definitions of incident and recompensated ascites, overt hepatic encephalopathy, variceal hemorrhage, bleeding because of portal gastropathy, and hepatocellular carcinoma were also codified. DISCUSSION: The LCN Cohort Study design will inform the natural history of cirrhosis in contemporary patients with compensated cirrhosis. The LCN Definitions and Measures Committee developed criteria for the definition of cirrhosis to standardize entry into this multicenter cohort study and standardized criteria for liver-related outcome measures. This effort has produced definitions intended to be both sensitive and specific as well as easily operationalized by study staff such that outcomes critical to the LCN cohort are identified and reported in an accurate and generalizable fashion. REGISTRATION: NCT05740358.
Health insurance literacy among patients receiving outpatient cancer treatment
Zhao, Jingxuan , Yabroff, K. Robin , Khera, Nandita , Yabroff, K Robin , Khera, Nandita , Zhang, Nan , Hilal, Talal , Griffin, Joan M.

Cancer | July 17, 2024 | Volume: 130 | Issue: 20 | Pages: 3480-3486

10.1002/cncr.35439 | PMID 39017818 Get It

Abstract Background This study examines patients’ understanding of health insurance terms and concepts and quantifies health insurance literacy (HIL) levels by key sociodemographic factors. Methods This study included 393 adult patients with cancer (>18 years old) receiving treatment in two ambulatory infusion centers: Mayo Clinic in Phoenix, Arizona and the University of Mississippi Medical Center in Jackson, Mississippi. Respondents’ perceptions of their HIL were assessed using the Health Insurance Literacy Measure (HILM), a validated 21‐item measure of a consumer's ability to select and use health insurance (HIL self‐efficacy). Respondents’ knowledge of health insurance concepts (HIL knowledge) was measured using 10 items created by the Kaiser Family Foundation. The number of correct answers was categorized into three levels: 0–4 (low knowledge), 5–6 (moderate knowledge), and 7–10 (high knowledge). Multivariable logistic regressions were used to compare correct answers to HIL knowledge questions by HIL self‐efficacy. Results Nearly three‐quarters of patients had high HIL self‐efficacy and high HIL knowledge (70.5%), understanding basic insurance terms, such as premiums and deductibles. Relatively low percentages of patients correctly answered questions about the meaning of provider networks, health insurance formularies, and calculating out‐of‐pocket spending in scenarios when insurers pay a portion of allowed charges. Lower HIL knowledge was more common among patients with less educational attainment (<college: 15.2%; ≥college: 4.7%), lower household income (<$4999: 11.8%; ≥$5000: 6.1%), and low HIL self‐efficacy scores (low: 24.8%; high: 5.2) (all p values <.05). Conclusions Efforts to improve HIL and navigation of health insurance plan features are required, especially for socioeconomically vulnerable patients.
CAR-T cells for H3K27-altered diffuse midline gliomas: where do we stand?
Millesi, Elena , Rechberger, Julian S. , Power, Erica A , Rechberger, Julian S , Power, Erica A. , Daniels, David J.

Immunotherapy | July 17, 2024 | Volume: 16 | Issue: 12 | Pages: 775-778

10.1080/1750743x.2024.2373043 | PMID 39016046 Get It

Randomized Feasibility Study Evaluating Multiple FDA-approved Microbubbles for CEUS Lymphography
Jang, Samuel , Rames, Jess D. , Hesley, Gina K. , Brinkman, Nathan , Tran, Nho V. , Fahradyan, Vahe , Lee, Christine U. , Fahradyan, Vahe

Plastic and Reconstructive Surgery - Global Open | July 17, 2024 | Volume: 12 | Issue: 7 | Pages: e5985

10.1097/gox.0000000000005985 | PMID 39022529 Get It

Summary: Prior studies on contrast-enhanced ultrasound (CEUS) lymphography for preoperative mapping before lymphaticovenous anastomosis surgery in patients with extremity lymphedema have been limited to using only Lumason and Sonazoid as microbubble contrast agents. The purpose of this study was to determine the feasibility of using two other Food & Drug Administration–approved microbubble agents, Optison and Definity, for imaging lymphatic vessels in the upper extremities. Nine female adults with unilateral upper extremity lymphedema anticipating lymphaticovenous anastomosis surgery underwent CEUS lymphography of the unaffected upper extremity randomized to either Lumason, Definity, or Optison. Lymphatic vessels were visualized in all but one case when undilated Definity was used. In the eight upper extremities where lymphatic vessels were visualized, an average of eight intradermal injections of microbubbles were performed in the extremity. Lymphatic vessels could be identified in 57% (36 of 63) of the injections. The effective dilution for each of the microbubble agents is provided. This was the first successful demonstration of lymphatic vessel visualization using either Definity or Optison. Broadening the range of available microbubble agents for CEUS lymphography could improve accessibility to the procedure and provide potentially safer alternatives.
Metabolomics Panel Associated with Cystic Fibrosis-Related Diabetes toward Biomarker Discovery
Mujammami, Muhammad , Mogren, Maha Al, AlMalki, Reem H. , Benabdelkamel, Hicham , Rahman, Anas M. Abdel , Almalki, Reem , Alabdaljabar, Mohamad S. , Abdel Rahman, Anas M , Nimer, Refat M. , Mogren, Maha Al

ACS Omega | July 17, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1021/acsomega.4c03626 | PMID 39100315 Get It

Topical Cannabidiol for Established Chemotherapy-Induced Neuropathy: A Pilot Randomized Placebo-Controlled Trial
D’Andre, Stacy D. , Novotny, Paul, Walters, Camille , Lewis-Peters, Susie, Thomé, Stephan D. , Tofthagen, Cindy , Loprinzi, Charles L. , D'Andre, Stacy , Tofthagen, Cindy S , Giridhar, Karthik V.

Cannabis & Cannabinoid Research | July 17, 2024 | Volume: 9 | Issue: 6 | Pages: No page available

10.1089/can.2023.0253 | PMID 39016024 Get It

Background: Patients have been known to use cannabinoids for treating established chemotherapy-induced peripheral neuropathy (CIPN) based on anecdotal information and retrospective reports suggesting that such might be beneficial. In response, a double-blinded, placebo-controlled, randomized, pilot clinical trial was developed to evaluate whether resultant data would support a phase III trial for testing whether a cannabidiol (CBD) cream might improve CIPN. Methods: Forty patients with established CIPN were randomized, in a double-blinded manner, to topical CBD or a placebo cream. The study product was applied for 2 weeks, followed by a crossover for 2 weeks. Neuropathy was evaluated using the European Organization of Research and Treatment of Cancer (EORTC)–CIPN20, the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool, and the Global Impression of Change instruments. Side effects were recorded by symptom diaries. Results: The EORTC-CIPN20 scores were similar in the patients receiving CBD versus the placebo. Likewise, the toxicity scores were similar in patients who received the CBD versus the placebo. Conclusions: This pilot trial did not support that the studied CBD isolate cream improved painful established CIPN. It was well tolerated overall. Clinical Trial Registration Number: NCT05388058
Predicting worsening heart failure with preserved ejection fraction from non‐invasive exercise testing
Reddy, Yogesh N.V. , Sundaram, Varun , Nishimura, Rick

European Journal of Heart Failure | July 17, 2024 | Volume: 26 | Issue: 12 | Pages: 2591-2594

10.1002/ejhf.3380 | PMID 39015082 Get It